Provo, Utah — 19 November 2020 — Hemplucid today applauded the overnight ruling by the highest court in the European Common Union that cannabidiol (CBD) is not a narcotic.
The decision early today by the Court of Justice of the European Union (CJEU) knocked-down efforts by certain EU member states and local courts to define CBD as a narcotic drug. The ruling further recasts the EU approach to cannabis, hemp, and CBD.
Such efforts have had a serious chilling effect during the past year on the marketing and sales of hemp and CBD products throughout the EU.
In addition, the CJEU also ruled that the EU’s Common Agricultural Policy (CAP) regulations on hemp — cannabis with under 0.2 percent of psychoactive THC (tetrahydrocannabinol) in the EU — were inaccurate because CBD “cannot be considered an agricultural product.”
Hence, CJEU’s decision likely removes intra-EU restrictions on CBD-hemp product sales and marketing.
Interestingly, the court also stated that unlike THC, CBD “does not appear to have any psychotropic effect or any harmful effect on human health.”
Hemplucid is a dedicated proponent for the free and unrestricted sale and marketing of all Industrial Hemp products around the world, but especially for CBD-hemp products.
Hence, we join with hemp advocates everywhere in applauding today’s ruling by the CJEU.
To read the CJEU news release on this decision, please visit https://curia.europa.eu/jcms/upload/docs/application/pdf/2020-11/cp200141en.pdf.